Roopa Industries has informed that a meeting of the Board of Directors of the Company is scheduled to be on November 14, 2015, to consider the Unaudited Financial Results of the Company for the quarter ended September 30, 2015. As per Roopa Industries - Code of Conduct for Prohibition of Insider Trading framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 1992, the trading window for dealing in securities of the Company shall remain closed for all Designated Employees (Sr. Manager and above), including Directors and such other employees of the Company who is in possession of any unpublished price sensitive information, irrespective of their designation, from November 10, 2015 to November 16, 2015 for the date of declaration of the Un-Audited Financial Results (Provisional) for the quarter ended on September 30, 2015.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: